InvestorsHub Logo
Followers 839
Posts 120670
Boards Moderated 13
Alias Born 09/05/2002

Re: None

Monday, 12/13/2021 7:04:16 PM

Monday, December 13, 2021 7:04:16 PM

Post# of 4882
GILD vs BMY in LBCL CAR-T—who has the edge?

https://www.fiercepharma.com/pharma/bristol-myers-squibb-breyanzi-gilead-yescarta-lock-horns-car-t-therapy-earlier-lymphoma

Both Yescarta and Breyanzi are poised to take share from stemcell transplants.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News